Market study phase 2 follow-up activity.  The Baylor Mark 3 Haploscope by unknown
General Disclaimer 
One or more of the Following Statements may affect this Document 
 
 This document has been reproduced from the best copy furnished by the 
organizational source. It is being released in the interest of making available as 
much information as possible. 
 
 This document may contain data, which exceeds the sheet parameters. It was 
furnished in this condition by the organizational source and is the best copy 
available. 
 
 This document may contain tone-on-tone or color graphs, charts and/or pictures, 
which have been reproduced in black and white. 
 
 This document is paginated as submitted by the original source. 
 
 Portions of this document are not fully legible due to the historical nature of some 
of the material. However, it is the best reproduction available from the original 
submission. 
 
 
 
 
 
 
 
Produced by the NASA Center for Aerospace Information (CASI) 
https://ntrs.nasa.gov/search.jsp?R=19780012815 2020-03-22T04:00:47+00:00Z
MARKET STUDY PHASE II FOLLOW-UP ACTIVITY
Ii	 i
The Baylor Mark III Haploscope
f I
	
	
(NASA-CR-156141) MUMA SIM PHASE 2	 P78-20758
POLLCW-UP ACTIVITY. THE PAYICE MAEN 3
BAPLMOPE (11T Research lost.) 23 F HC
,^	 A02/MF A01	 CSCL 06E	 unclas
G3/52 15216
1
y 1
r
I	 ^
T
J.
1	 Contract - NASW 2837
MARKET STUDY PHASE II FOLLOW-UP ACTIVITY
The Baylor Mark III Haploscope
`
j	 Prepared for:
Technology Utilization Office
National Aeronautics and Space Administration
Washington, D.C.
Prepared by:
Management and Techno/Economic Services Section
IIT Research Institute
10 West 35th Street
Chicago, Illinois	 60616
312/567-4651
December, 1977
TABLE OF CONTENTS
Page
1. INTRODUCTION .......................................... 	 1
2. BACKGROUND ............................................ 	 1
3. APPROACH .............................................. 	 3
4. RESULTS ............................................... 	 7
5. CONCLUSIONS AND RECOMMENDATIONS ....................... 	 13
APPENDIX
A. Letter of Transmittal to Interested Manufacturers 	 16
B. Letters from Manufacturers Defining their Final Position 19
-^` t
i i'
i1f^
ylI
fr	
^ r
n Fl,
t-
91 _
til -
1. INTRODUCTION
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This report documents our summary findings regarding a
follow-up to the Phase II market assessment of the Baylor Mark III
Haploscope. The Phase II activity is documented in IITRI's report
"Computerized Binocular Vision Testing": A Market Study of the
Baylor Mark III Haploscope', dated March 15, 1977. The objectives
of our recent follow-up efforts have been to:
• Accelerate Commercialization of the Haploscope
® Develop an Approach to Quickly and Reliably Determine
Level of Manufacturer Interest in NASA items such
as the Haploscope
Define the General Nature of the Decision Making
Process within Firms as it Concerns Project Selection
and Potential new Product Evaluation
• Assess the Implications for the NASA Marketing Program
We accomplished these objectives thru consideration of our
Phase II findings of the haploscope. The NASA contractor report,
NASA CR-25847 I The Mark III Haploscope' was used in conjunction with
the Phase II study as a means of presenting to appropriate manu-
facturers tha capabilities and potential which the device may have
to compliment their product line. The contractor report describes
the technical attributes of the haploscope, both as it has been
developed to date, and as it has the potential for being developed
in the future. Our overall goal is to utilize these two tools
to impact on appropriate manufacturers in the market place as
quickly and effectively as possible.
2. BACKGROUND
The computerized binocular vision tester (i.e. haploscope)
was developed initially for the space program under a contract of
NASA Ames to Baylor College of Medicine. It was recognized that the
concept could be applied to vision testing situations on earth as
well. The device offers the primary advantages of speed coupled
with accuracy, flexibility for testing a variety of vision parameters,
and compatibility with a computerized vision diagnosis and documentation
-1-
center concept. There are other computerized vision testers on the
market at the present time, but they do not preclude the possibility
of a market need for the haploscope. the haploscope concept has been
published in the literature (e.g., Optical Engineering, Vol. 15
—	 no. 4, July - August 1976), and no patents exist to date.
_	 The findings of our Phase II study were mixed as determined
by the immediate vs. long-term realities of the market place.
The long-term outlook for computerized vision care is positive and
indicates considerable market opportunity. This is based on our
determination that the following trends will create a demand for
greater vision care efficiency and effectiveness:
	 l
Some form of national health insurance
a Growth of Health Maintenance Organizations
• Increased emphasis on vision care as it relates to
education and job performance
a A general increase in population (particularly over 65)
which stresses the present vision care facilities
a A more computer-oriented group of potential users	 1
(ophthalmologists, optometrists and technicians) are only
	 1
beginning to have an impact on purchase decisions
All o',' these factors define the need for more efficient,
accurate ,and reliable instrumentation, as well as coordination of
the instrumentation. The computer is certain to play a large role
in satisfying these needs.
The Phase II study findings also defined barriers which restrict
the immediate market acceptance of a device such as the haploscope.
There is a product acceptance lag after market introduction which has
been demonstrated by other computerized devices already on the market.
Cost As the main constraint. Justification for purchase can
generally be made on the basis of high patient load situations. Just
as important as cost, though less tangible, is the education time
frame and personal perspertive of the en&user and frequent specifier,
_	 the practitioner. The real purchase potential of computerized
instrumentation, aside from high volume clinics, lies with those
practitioners who will be graduating in the future. These users will
be familiar with computerized instruments and will need to purchase
-2-
_
a 7 --. -
equipment as they begin private practice or as they become influential
in the purchase decision in clinics, group practice, or hospital
service.
The overall market potential as a result of these factors is
characterized as low in the near future (5-10 years) but high in
the long tirm as the vision care industry matures technologically
and is forced to respond with greater effectiveness to the needs
of the population. It is this outlook and time frame which plays
a key role in a manufacturer's assessment of the haploscope's
commercialization potential. These issues will be addressed in the
course of this follow-up report in order to accomplish the objectives
set forth in the introduction to the mutual benefit of NASA,
interested firms and potential end-users.
3. APPROACH
We accomplished our objectives by first considering the nature
of the commercialization decision-making process in the vision
instrumentation industry, and then structuring a- setof tasks in
order to interject into this decision-making process at the proper
organization level. The chart on the following page illustrates
the various roles and interactions which are critical in assessing
the potential of a new product as a candidate for commercialization.
It is clear that in a complex, product-oriented firm it is the
product manager who by-and-large has the overall perspective,
and often the responsibility for coordinating engineering, marketing
and sales information. Depending on the particular organization
structure, this role may also be assumed by the marketing manager.
The quickest means of determining the commercial interest in
a NASA item such as the haploscope is to identify the product
manager and provide him with sufficient information (preferably
in the form of written reports) with which to make or obtain a
,judgement. Usually several stages of discussion are necessary
for him to provide a response representing the organization. This
may include review by R&D, marketing, engineering, a management
product planning committee or the president.
-3-	
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-4-
Some firms utilize outside, individual consultants or authorities
at universities or with medical affiliations who may have_an added
perspective on the needs of the marketplace.
This process consumes several weeks or months depending on
the sophistication of the decision-making process, the particular
time of year (e.g., before or after next fiscal year budget level,
have been fixed and priorities established), the particular
interest of the firm in technology developed elsewhere or the degree
of synergism with the existing product line. These are elements
of a new product evaluation process which is typical of high
technology, commercial product-oriented firms. A more comprehensive
listing of such elements is provided on the following page.
Our knowledge about this new product evaluation process was
utilized to develop a set of tasks which makes use of our industry
contacts and previous market findings from the Phase II study.
We focused on those potential manufacturers who are presently
engaged in or known to be interested in entering the computerized
vision instrument field. On this basis we structured the following
tasks:
• Compile a list of manufacturers of competitive
products related to the generic nature of the
haploscope and similar products used in vision
cave.
• Contact product managers within each target firm
who have responsibility and control of engineering,
marketing and sale of a vision testing product
and discuss the following:
- Define NASA's objective to disseminate technology
to industry, and IITRI's marketing role in this process
Describe the product (i.e., the haploscope) in
terms which compare it to presently marketed
products
- Establish whether any interest exists on the part
of the manufacturer for commercializing the product
development
Refer the product manager to the innovator and to
NASA Headquarters for further in-depth technical or
commercialization information. 	 ORIGINAL PAU .
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NEW-PRODUCT EVALUATION CHECKLIST
• RESEARCH AND DEVELOPMENT
EXTENT OF RESEARCH KNOW-HOW
PATENT STATUS
CHANCE OF TECHNICAL SOLUTION
MANPOWER AVAILABILITY
EXTENT OF TECHNICAL SERVICE REQUIRED
j MARKET RESEARCH
ESTIMATED SIZE OF MARKET
MARKET TREND
PRICE AND DEMAND STABILITY
PRODUCT COMPETITION
• MARKET DEVELOPMENT
CHANCE OF COM14ERCIAL SUCCESS
MARKET DEVELOPMENT REQUIREMENTS
TIME REQUIRED TO COMMERCIALIZE
VALUE ADDED TO CUSTOMER'S PRODUCT
SIMILARITY TO PRESENT PRODUCT LINES
SALES
EFFECT ON PRESENT PRODUCTS
REQUIREMENT FOR TECHNICAL SERVICE
SUITABILITY OF PRESENT SALES FORCE
SALES COSTS
NEW CUSTOMERS--TYPE AND QUALITY
ESTIMATED ANNUAL SALES
CAPTIVE USE
MANUFACTURING
REQUIRED CORPORATE SIZE
FACILITY AVAILABILITY
PROCESS FAMILIARITY
AVAILABILITY OF RAW MATERIALS
• FINANCE AND CONTROL
ANTICIPATED RETURN ON INVESTMENT (BEFORE TAXES)
NEW FIXED CAPITAL PAYOUT TIME
RATIO OF PRODUCTION COST TO SELLING PRICE
RESEARCH AND DEVELOPMENT COST PAYOUT TIME
RATIO OF RESEARCH COST TO MARKET POTENTIAL
• CORPORATE
CONTRIBUTION TO COMPANY GOALS
CONTRIBUTION TO CORPORATE IMAGE
POSSIBLE GOVERNMENT REACTION
-6-
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• Send the contractor	 report and the Phase II
market study to those manufacturers who are interested.
See Appendix A for a letter of transmittal to a
potential manufacturer.
• Follow up as frequently as individual circumstances
warrant in order to determine the status, opinions
about and disposition of the information and
consideration of the haploscope
• Continue to encourage the manufacturer to contact
NASA and the innovator to facilitate the exchange of
information
• Assess the results of our activity by definin g the real
opportunities for commercialization, and the rationale
of the manufacturers who decide not to pursue
commercialization
_ • Prepare and submit a summary report to NASA with
findings and recommendations regarding the haploscope
"r and commercialization enhancement approaches used in
the course of this follow-up activity or recommended
:. for future consideration.
This process described by the above statements, consists of
company targeting, key individual identification, information exchange
and repetitive contact over an extended period of time. It is
useful in presenting a NASA item for commercialization and defining
its potential as quickly as possible. The following section defines
the results -)f our efforts utilizing the process defined above.
4. RESULTS
The results of our activity are defined according to the initial
objectives set forth in the introduction. The development of a
general approach for quickly determining manufacturer interest, and
the acceleration of the commercialization of the haploscope provide
the perspective for reviewing the following findings.
The decision-making process was characterized in the previous
section as being strongly a function of the role of individuals and
their interaction, as well as the entire corporate philosophy,
orientation and goals. Tables i and 2 on the followinq pages
profile the potential manufacturers and their, interest during the
study.
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The key decision-makers are defined and their opinions are recorded
at several key steps of the decision-making process- of the firms.
It is irrportant to tote the impact of forwarding the reports (both
technical and market) on the opinions and interest level of the
managers interviewed. Submission of documentation of this type is
necessary to quickly and reliably identify the seriously interested
firms and carry on a productive commercialization dialogue.
The specific finings regarding %;ommercial interest in the
haploscope are presented as Table 3 following. The overall result
is that no firm is seriously interested in commercializing the
.`	 haploscope at the present time. There is no one overriding rationale
for their decision, but rather a variety of responses which are a
function of both individual firm characteristics and the attributes
of the haploscope in relation to the present market status of
computerized vision instrumentation. These factors are defined
11	
more explicitly in the following section.
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TABLE 3
SUMMARY OF MANJFA.CTURER INTEREST IN HAPLOSCOPE
POTENTIAL MANUFACTURER INTEREST RATIONALE
ACUITY SYSTEMS NO s RELY ON INTERNAL R&D (NOT INVENTED HERE)
` AMERICAN OPTICAL NO s WILL NOT FIT IN EXISTING PRODUCT LINE
tl s NOT INVENTED HERE
BAUSCH & LOMB NO s TOO EXPENSIVE TO GENERATE SIZEABLE
11 DEMAND
f/ s TOO RESEARCH-ORIENTED IN TERMS OF
APPLICATION
i COHERENT RADIATION NO s INTEREST	 PRESENT	 DUE TOj
-.r
MANAGER
 
CHANGES OCCURRING
GULF & WESTERN NO s CANNOT JUSTIFY PRODUCT LINE EXPANSION AT
' THIS TIME DUE TO OTHER COMMITMENTS
s EXPRESSED INTEREST IN SEEING HAPLOSCOPE
HONEYWELL NO s NO INTEREST IN ENTERING THIS PARTICULAR
COMMERCIAL MARKET
HUMPHREY INSTRUMENTS NO s TOO EXPENSIVE
s MUCH ADDITIONAL DEVELOPMENT REQUIRED
s NOT DIFFERENTIABLE FROM PRESENT PRODUCT
KEYSTONE VIEW NO • LOW MATCH WITH PRESENT CAPABILITIES
(i.e., NO ELECTRONICS/COMPUTER EXPERTISE)
3
NARCO NO s DROPPING., PRESENT LINE OF EYE--TRACKING
INSiRU:MENTS
+_ v TITMUS OPTICAL NO s NOT IN LINE WITH COMPANY OBJECTIVES
!k
s DOES NOT ADDRESS CURRENT MARKET DEMAND
1
TRACOR NO s NO DESIRE TO COMMIT TO DEVELOPMENT EFFORT
AT PRESENT TIME
s MAY REVIEW AS POSSIBLE DEVELOPMENT
PROJECT FOR 1979
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D5. CONCLUSIONS AND RECOMMENDATIONS
Conclusions
There are several key conclusions which are drawn concerning
the nature of our follow-up activity. Our conclusions are that
the follow-up activity can:
• INITIATE INDUSTRIAL INVOLVEMENT EARLY-ON IN ORDER TO:
- Contribute Resources
- Provide Product Definition
- Provide Market Perspective
,^	 • PROVIDE ADDED DIMENSION TO MARKET STUDIES BY OBTAINING TECHNICAL/
MARKETING APPRAISAL FROM INDUSTRY:
- At High Strategic Levels of Corperate Decision Making
j	 - For Direct Comparison of NASA Technology to 'In-House'
Research Projects @ Project Selection Level
- To Stimulate Interest, Involvement, Action, Commitment
• REDUCE UNCERTAINTY/RISK ASSOCIATED WITH NASA's PROJECT
SELECTION BY:
- Providing Greater Opportunity for Firms to Study Information
- Giving Firms More Time to Consider Product Potential
- Involving ,More Decision Makers (With a Diversity of
Responsibilities and Background)
- Permitting More Serious Assessment than Possible over Phone
• AMPLIFY THE VISIBILITY OF NASA AS A POTENTIAL SOURCE OF PRACTICAL,
PROBLEM-SOLVING TECHNOLOGY
At the same time conclusions about the commercialization of
the haploscope can also be made in the context of the rationale
presented by the firms which were contacted. These are summarized
below:
• The market place for vision instrumentation is not perceived
as sophisticated enough as yet to generate substantial
demand.
• The haploscope does not provide a clear product differentiation
from existing computerized vision instruments or superiority
1	 to these instruments.
1
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	a There exists a 'not-invented-here' syndrome^ 	 rome among the major
ophthalmic goods manufacturers, and a rel;ictnace to invest
in aroduct without clear rights and rp	 g	 p^',vi1ages of manu-
facture and without some degree of technical synergism with
existing products being offered.
s The payback period is regarded as too long, with the true
potential too far in the future to justify investment at
the present time in substantial technical and market development.
The haploscope as it has been developed to-date requires a
I
total redesign in order to up-date the technology and address
more directly the needs of the practitioner.
Recommendations
	
1	 Specific recommendations can be made regarding the follow-up
process as a tool in the transfer of aerospace technology to
industry. The main aim of accelerating the commercialization
process in selected instances is accomplished thru the following
recommended methodology:
Z1 a	 CONDUCT 'PHASE III' FOLLOW-UP FOR SELECTED STUDIES WHERE
u -	 NASA Agrees Follow-Up is Appropriate
-	 Technology is Developed to Prototype St?ge and Performance Data
is Available
-	 Item is Preferably 'TU' Derived
s	 SUBMIT PROPOSAL FOR PHASE III STUDY WHICH WILL
-	 Define Scope
-	 Specify Tasks
-	 Estimate Time and Cost
•	 CONDUCT PHASE III STUDY WITH AN APPROACH BASED ON
-	 Phone Interviews
-	 Personal Interviews as Required
-	 A Duration Dependent on Potential Manufacturer's Decision-
Making (3-6 Months Typical)
-	 Submittal of Monthly Status Reports
e	 SUBMIT FINAL LETTER REPORT INDICATING
-	 Seriously Interested Manufacturers and Their Preliminary
Recommendations for Commercialization'
-	 Rationale for Lack of Interest
1	 -14-
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I
	
w_E1{	 IIT Research Institute}	 I	 10 Nest 35 Street, Chicago, Illinois 60616
	
u t1^	 312/56-7-4000
I
I	 May 31, 1977
I
Mr. Dave Henderson
Ophthalmic Instruments Product Manager
Bausch E Lomb
1400 N. Goodman
Rochester, New York 14602
Dear Mr. Henderson:
I appreciated the opportunity to discuss the NASA Technology
Utilization Program with you regarding a computerized binocular
vision tester. This instrument was developed at the Ophthalmic
Systems Research Laboratory of Baylor College of Medicine, Houston
and funded by National Aeronautics and Space Administration thru
their Ames Research Center, Moffett Field, Californ'.a. We have a
NASA contract at IIT Research Institute to evaluate the commercial
potential of the device (as well as other products developed for
various NASA missions) in relation to the marketplace. The results
of our p reliminary market study are then utilized as a project
selection and prioritization tool by NASA's Office of Technology
Utilization in Washington, D.C.
Our work also involves the determination of which manufacturers
of related products may represent significant prospects for commer-
cializing the NASA developments. As a result of your interest in
the vision tester, I am enclosing with this letter a copy of our
market study entitled "Computerized Binocular Vision Testing." A
NASA Contractor Report CR-2584, "The Baylor Mark III Haploscope,"
which presents the technical aspects of the instrument, will be for-
warded to you as soon as possible. Please review the reports at
your earliest convenience and feel free to contact me if you have
any questions.
As you become familiar with the instrument and its cat,abilities,
you can address any questions regardin g the development work to Dr.
Thomas Decker and any questions regarding the means for obtaining
the technology to Mr. Ray Whitten as follows:
I
I
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I
I
I
I
I
I
I
I
I
I
Dr. Thomas A. Decker
Director, Ophthalmic Systems
Research Laboratory
Baylor College of Medicine
Texas Medical Center
Houston, Texas 77030
713/797-0291
Mr. Ray P. Whitten
Biomedical Applications
Program Manager
Technology Utilization Office
NASA Headquarters
Code KT
Washington, D.C. 20546
202/755-3140
f
TMJ/dlb
{ enclosure
s,
•F
I^
r	 1
_^
1*K~ f a
Associate
Techno/Economic Studies Group
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I look forward to discussin g the potential of the computerized
vision tester further with you in the near future.
r Sincerely,
^!	 ",rJ vw •4^ ^
	
,s
Thomas M. Jacobi s
^. V
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BAUSCH & LOMB O
SCIENTIh; O PTICAL PRODUCTS DIVISION • OPTICS CENTER • 1400 NORTH GOODMAN STREET • ROCHESTER, NEW YORK 14602 • (7161 3366000
J	
July 27, 1977
Mr. Thomas M. Jacobius
IIT Research Institute
7	 10 West 35 Street
J	 Chicago, IL 60616
Dear Mr. Jacobius:
Thank you for the information you sent me on the Mark III Haploscope.
As I mentioned to you, we are not in a position at the present time to
pursue a project of this nature.
y
J
I've showed the two reports to some of our people and their general
comment was that an instrument such as this would be basically a
research tool.	 Because of its cost, I don't know if it could be
developed into a commercial item.	 You might be interested in know-
ing that a few years ago B&L did some work on a Haploscope.
	
A single
instrument was developed and after much effort we found practically
no interest in it.
Regarding the market size and potential sales, my general reaction
is that with selling price of $15-20K, there would be a much smaller
number among O.D.'s and M.D.'s who would purchase such equipment.
They would have to have extremely high volume practices in order
to ,justify such instrumentation.
I hope this information is helpful to you.
Sincerely,
DFH:sam	 David F. Henderson, Jr.
Product Manager
Ophthalmic Instruments
_..	 -	 ^rrs^ : vrncnti mc... r€TER5114RO VIM 151NIA 2a9L73 U-5A, aue .. /oa10141
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8 September 1977	 7	 U"
A ZEISS COMPANY
Mr. Thomas M. Jacobius
ITT Research Institute
10 West 35 Street
Chicago, Illinois 60616
-'	 Dear Tom:n•4`Y
We have throughly reviewed the information you provided on the Computerized
Binocular Vision Tester developed by NASA. Based upon our understand of
the vision screening markets and our objectives, we do not feel this
technology is of value to us at this time. We would however like to
keep the door open for future consideration. Therefore, we have taken
the liberty of retaining the information you submitted. If we should
	
'i	 want to re-open our discussion, we will contact you.
	
^	 Thank you for your consideration, and if we can ever be of service
please call.
Sincerely yours,
W. Bruce Cavey
Manager
1	 Product Marketing
i	 dkeTHB
I
1	 •
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